T2 Biosystems Stock (NASDAQ:TTOO), Quotes and News Summary

Q: What sector and industry does T2 Biosystems (TTOO) operate in?

T2 Biosystems is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

T2 Biosystems Stock (NASDAQ: TTOO) stock price, news, charts, stock research, profile.

Open	-
Close	-
Volume / Avg.	0 / 245.614K
Day Range	- - -
52 Wk Range	2.700 - 70.000
Market Cap	$16.482M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	41
Short Interest	8.47%
Days to Cover	1.11

Recent News

Why Big Lots Shares Are Trading Lower By Around 31%? Here Are Other Stocks Moving In Monday's Mid-Day Session

Shares of Big Lots, Inc. (NYSE: BIG) fell sharply during Monday’s session after the company reported preliminary fourth-quarter results. Also, Loop Capital downgraded the stock from Hold to Sell and lowered its price target from $6 to $1.

Avi Kapoor

Why T2 Biosystems Stock Is Up Today

T2 Biosystems said that it has received FDA clearance to add the capability to detect another bacterial species, Acinetobacter baumannii, to the panel. "We are thrilled to receive the FDA 510(k) clearance for the expanded T2Bacteria Panel, to include the detection of A. baumannii, as we believe it will lead to increased adoption of our proprietary direct-from-blood platform," stated John Sperzel, CEO of T2 Biosystems.

Erica Kollmann

Why In Vitro Diagnostics Company T2 Biosystems Shares Gaining Today

T2 Biosystems, Inc. (NASDAQ: TTOO) shares are trading higher on Wednesday after the company submitted a 510(k) premarket notification to the U.S.

Nabaparna Bhattacharya

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Rating

3.0

Hold

Strong Buy

Buy

Hold

Sell

Strong Sell

About T2 Biosystems Inc

Sector

Health Care

Industry

Biotechnology

T2 Biosystems Inc is a leader in the rapid detection of sepsis-causing pathogens and antibiotic resi...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy T2 Biosystems (TTOO) stock?

You can purchase shares of T2 Biosystems (NASDAQ: TTOO) through any online brokerage.

View our list of the best stock brokerages.

Who are T2 Biosystems's (TTOO) competitors?

Other companies in T2 Biosystems’s space includes: Vincerx Pharma (NASDAQ:VINC), Eterna Therapeutics (NASDAQ:ERNA), Galecto (NASDAQ:GLTO), Immuron (NASDAQ:IMRN) and Dominari Holdings (NASDAQ:DOMH).

What is the target price for T2 Biosystems (TTOO) stock?

The latest price target for T2 Biosystems (NASDAQ: TTOO) was reported by Alliance Global Partners on Thursday, July 13, 2023. The analyst firm set a price target for 0.07 expecting TTOO to fall to within 12 months (a possible -97.66% downside). 1 analyst firms have reported ratings in the last year.

Current Stock Price for T2 Biosystems (TTOO)?

The stock price for T2 Biosystems (NASDAQ: TTOO) is $2.99 last updated April 18, 2024 at 4:03 PM EDT.

Does T2 Biosystems (TTOO) pay a dividend?

There are no upcoming dividends for T2 Biosystems.

When is T2 Biosystems (NASDAQ:TTOO) reporting earnings?

T2 Biosystems’s Q1 earnings are confirmed for Monday, May 13, 2024.

Is T2 Biosystems (TTOO) going to split?

There is no upcoming split for T2 Biosystems.

What sector and industry does T2 Biosystems (TTOO) operate in?

T2 Biosystems is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

-

-

-

-

-

-

-

-

-

-

-

-

-

-